Nov 05, 2020 / 01:00PM GMT
Operator
Ladies and gentlemen, welcome to the Camurus Q3 report for 2020. Today, I am pleased to present the President and CEO, Fredrik Tiberg. (Operator Instructions) Speakers, please begin.
Fredrik Tiberg - Camurus AB(publ)-CEO - President, Head of Research & Director
Thank you so much. Good afternoon, everyone, and welcome to our third quarter presentation. Hope you're all doing well in these very unusual COVID-19 times.
Before I go into the presentation, I just want to alert you to our forward-looking statements on Slide #2. And with that, moving forward to Slide #3. So in today's call, we will update you on our continued business progress with the commercialization of Buvidal as well as provide a brief update on key R&D programs. We will finish off with key takeaways and a Q&A session. With me in today's call is our Chief Commercial Officer, Richard Jameson; and our Chief Financial Officer, Eva Pinotti-Lindqvist.
So let's move to Slide 4 and some highlights during the third quarter. You have
Nine Months 2020 Camurus AB Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
